0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Divalproex Sodium"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Anticonvulsants Market Report 2025 - Product Thumbnail Image

Anticonvulsants Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Grand Mal Seizure Treatment Market Report 2025 - Product Thumbnail Image

Grand Mal Seizure Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Seizures Pipeline Insight Analysis Report - Product Thumbnail Image

Seizures Pipeline Insight Analysis Report

  • Drug Pipelines
  • August 2024
  • 150 Pages
  • Global
From
EUR$2,789USDGBP
  • 5 Results (Page 1 of 1)
Loading Indicator

Divalproex Sodium is a drug used to treat various conditions related to the Central Nervous System (CNS). It is an anticonvulsant and mood stabilizer used to treat epilepsy, bipolar disorder, and migraine headaches. It is also used to treat certain psychiatric disorders, such as schizophrenia and schizoaffective disorder. Divalproex Sodium is available in both immediate-release and extended-release formulations. The extended-release formulation is used to treat manic episodes associated with bipolar disorder. Divalproex Sodium is a widely used drug in the CNS market. It is generally well-tolerated and has a low risk of side effects. It is also relatively inexpensive compared to other CNS drugs. Some companies in the Divalproex Sodium market include AbbVie, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more